In 2023, the Base Editing Market was valued at $270 million and is poised to reach $549 million by 2028, growing at a CAGR of 15.2%. This research report dives deep into industry trends, pricing strategies, patent landscapes, and materials from conferences and webinars. Key stakeholders and consumer purchasing behaviors are also analyzed. The market’s growth is primarily driven by the increasing prevalence of genetic diseases and the rising understanding of genetic mutations, which have fueled the demand for accurate gene editing technologies.
Download an Illustrative overview
The platform segment accounted for the largest share by product & service in the base editing market in 2022.
By product and service, the base editing market has been further categorized as products and services. The service segment is further categorized as gRNA design, cell line engineering, and other services. The product segment is further categorized as platform, kits & reagents, plasmids, and base editing libraries. Platform accounted for the largest share of the global base editing market in 2022. The large share of this segment can primarily be attributed to the factor that it offers integrated solutions that combine various elements required for the editing process, such as the base editor protein, guide RNA, and delivery mechanisms. This integration simplifies the workflow for researchers, as they can obtain a complete solution from a single source rather than assembling individual components.
The DNA base editing type segment is expected to grow at a higher rate during the forecast period 2023-2028.
Based on the type, the global base editing market is segmented into RNA base editing, and DNA base editing. In 2022, DNA base editing accounted for the largest share of the base editing market and the segment is expected to grow at a higher rate during the forecast period. The prominence of this segment is mainly attributed to the factor that once a base is edited in the DNA, the change is more stable over time compared to RNA-based editing. RNA is typically transient in cells, and the edits made to RNA may not persist as long as those made to DNA.
The pharmaceutical & biopharmaceutical companies segment accounted for the largest share of the end user segment in the base editing market in 2022.
Based on end users, the base editing market has been segmented into pharmaceutical & biotechnology companies, academic research institutes, and contract research organizations. In 2022, the pharmaceutical & biotechnology segment accounted for the largest share of the base editing market. One of the major factors driving the growth of this segment is that base editing enables precise modifications at the DNA or RNA level, allowing pharmaceutical and biotech companies to develop targeted therapies for specific genetic diseases. This aligns with the industry’s shift toward precision medicine, where treatments are tailored to the individual genetic makeup of patients.
The North American region catered for the largest share of the base editing market in 2022.
The base editing market is segmented into North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), and the Middle East and Africa (MEA). The availability of funding, both public and private, plays a crucial role in the development and commercialization of advanced technologies. North America has a well-established infrastructure for funding research and development initiatives, providing financial support to companies working on base editing technologies.
Base Editing Market Dynamics:
Drivers:
- Increasing government funding and growing focus on genomic studies
- Increased applications of genomic research in pharmaceuticals
- Rising prevalence of rare diseases
- Increased precision, better safety, and reduced off-target effects
Restraints:
- Ethical and safety concerns
Opportunities:
- Increasing pipeline of gene therapy products and regulatory approvals
Challenge:
- Lack of expertise to develop base editors with higher specificity
Key Market Players of Base Editing Industry:
Key players in the base editing market include Danaher Corporation (US), Merck KGaA (Germany), Revvity (US), Maravai LifeSciences (US), GenScript (China), Beam Therapeutics (US), Intellia Therapeutics, Inc. (US), Cellectis (France), ElevateBio (US), Creative Biogene (US), Bio Palette Co., Ltd (Japan), Addgene (US), Synthego (US), Edigene, Inc. (China), Shape TX (US), Pairwise (US), ProQR Therapeutics (Netherlands), QI- Biodesign (China), KromaTiD, Inc. (US), and GenKOre. (South Korea).
Get 10% Free Customization on this Report
Base Editing Market Recent Developments:
- In May 2023, Revvity entered into a license agreement with AstraZeneca for the technology underlying its Pin-point base editing system, a next-generation modular gene editing platform with a strong safety profile to support their creation of cell therapies for the treatment of cancer and immune-mediated diseases.
- In July 2022, Beam Therapeutics entered a collaboration with Verve Therapeutics. Beam Tx granted Verve Tx a license toward an additional liver-mediated cardiovascular disease target.
- In February 2022, Intellia Therapeutics acquired Rewrite Therapeutics; a private biotechnology company focused on advancing novel DNA writing technologies. This acquisition has expanded Intellia’s industry-leading genome editing toolbox by adding a platform that is highly complementary to its existing CRISPR/Cas9 and base editing technologies.
Base Editing Market – Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall base editing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
Content Source:
https://www.marketsandmarkets.com/PressReleases/base-editing.asp
https://www.marketsandmarkets.com/Market-Reports/base-editing-market-21238371.html
